Exact Mass: 476.2223576

Exact Mass Matches: 476.2223576

Found 358 metabolites which its exact mass value is equals to given mass value 476.2223576, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Loperamide

4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide

C29H33ClN2O2 (476.22304280000003)

Loperamide is an opioid receptor agonist and acts on the mu opioid receptors in the myenteric plexus large intestines; it does not affect the central nervous system like other opioids; Loperamide usually as hydrochloride, is a drug effective against diarrhea resulting from gastroenteritis or inflammatory bowel disease. In most countries it is available generically under brand names such as Lopex, Imodium, Dimor and Pepto Diarrhea Control; Treatment should be avoided in the presence of fever or if the stool is bloody. Treatment is not recommended for patients who could suffer detrimental effects from rebound constipation. If there is a suspicion of diarrhea associated with organisms that can penetrate the intestinal walls, such as E. coli O157:H7 or salmonella, loperamide is contraindicated; Loperamide, usually as hydrochloride, is a drug effective against diarrhea resulting from gastroenteritis or inflammatory bowel disease. In most countries it is available generically under brand names such as Lopex, Imodium, Dimor and Pepto Diarrhea Control; it does not affect the central nervous system like other opioids; One of the long-acting synthetic antidiarrheals; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally; Loperamide is an opioid receptor agonist and acts on the mu opioid receptors in the myenteric plexus large intestines [HMDB] Loperamide is an opioid receptor agonist and acts on the mu opioid receptors in the myenteric plexus large intestines; it does not affect the central nervous system like other opioids; Loperamide usually as hydrochloride, is a drug effective against diarrhea resulting from gastroenteritis or inflammatory bowel disease. In most countries it is available generically under brand names such as Lopex, Imodium, Dimor and Pepto Diarrhea Control; Treatment should be avoided in the presence of fever or if the stool is bloody. Treatment is not recommended for patients who could suffer detrimental effects from rebound constipation. If there is a suspicion of diarrhea associated with organisms that can penetrate the intestinal walls, such as E. coli O157:H7 or salmonella, loperamide is contraindicated; Loperamide, usually as hydrochloride, is a drug effective against diarrhea resulting from gastroenteritis or inflammatory bowel disease. In most countries it is available generically under brand names such as Lopex, Imodium, Dimor and Pepto Diarrhea Control; it does not affect the central nervous system like other opioids; One of the long-acting synthetic antidiarrheals; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally; Loperamide is an opioid receptor agonist and acts on the mu opioid receptors in the myenteric plexus large intestines. A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07D - Antipropulsives > A07DA - Antipropulsives C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals KEIO_ID L047; [MS2] KO009036 KEIO_ID L047

Nalfurafine

N-[4-(cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-yl]-3-(furan-3-yl)-N-methylprop-2-enamide

C28H32N2O5 (476.2311102)

Fuscaxanthone A

7-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-5,9-dihydroxy-8-methoxy-2,2-dimethyl-2,6-dihydro-1,11-dioxatetracen-6-one

C29H32O6 (476.2198772)

Methyl 1-benzoyl-20-hydroxy-17-methoxyaspidospermidin-21-oate #

C28H32N2O5 (476.2311102)

(S)-Amorin

C29H32O6 (476.2198772)

2-(4-Methyl-3-pentenyl)-2-methyl-5,10-dihydroxy-9-methoxy-12-(1,1-dimethyl-2-propenyl)-2H,6H-pyrano[3,2-b]xanthene-6-one

C29H32O6 (476.2198772)

Fuscaxanthone A

C29H32O6 (476.2198772)

7,7-dimethyl-5,7-epoxypyrano[3,3:2,3]-2-(3-methyl-but-2-enyl)-dibenzo[b,f]pyrano[2,3-d]oxepin-3,7-diol|artocarpol F

C29H32O6 (476.2198772)

Cowaxanthone C

C29H32O6 (476.2198772)

(+)-angelicoidenol 2-O-[6-O-S-3-hydroxy-3-methylglutaryl]-beta-D-glucopyranoside|zingiberoside C

C22H36O11 (476.22575059999997)

Asp Ser Gln Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxypropanamido]-4-carbamoylbutanamido]hexanoic acid

C18H32N6O9 (476.22306620000006)

Thr Asn Asp Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-carboxypropanamido]hexanoic acid

C18H32N6O9 (476.22306620000006)

loperamide

C29H33ClN2O2 (476.22304280000003)

A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07D - Antipropulsives > A07DA - Antipropulsives C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals CONFIDENCE standard compound; INTERNAL_ID 2504 CONFIDENCE standard compound; INTERNAL_ID 8489

Ala Cys Gln Arg

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanoic acid

C17H32N8O6S (476.21654120000005)

Ala Cys Arg Gln

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-4-carbamoylbutanoic acid

C17H32N8O6S (476.21654120000005)

Ala Gln Cys Arg

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanoic acid

C17H32N8O6S (476.21654120000005)

Ala Gln Arg Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanoic acid

C17H32N8O6S (476.21654120000005)

Ala Arg Cys Gln

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C17H32N8O6S (476.21654120000005)

Ala Arg Gln Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C17H32N8O6S (476.21654120000005)

Cys Ala Gln Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanoic acid

C17H32N8O6S (476.21654120000005)

Cys Ala Arg Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-5-carbamimidamidopentanamido]-4-carbamoylbutanoic acid

C17H32N8O6S (476.21654120000005)

Cys Glu Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carboxybutanamido]-3-methylpentanamido]-3-methylpentanoic acid